Yalcinkaya, M., Liu, W., Xiao, T., Abramowicz, S., Wang, R., Wang, N., Westerterp, M., & Tall, A. R. (2024). Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis. Journal of Lipid Research, 65(4), 100534. https://doi.org/10.1016/j.jlr.2024.100534

Kendir-Demirkol, Y., Jenny, L. A., Demir, F., & Sözeri, B. (2023). Evaluation of common NLRP3 Q703K variant in pediatric patients with autoinflammatory disease: CAPS and PFAPA. The Turkish Journal of Pediatrics, 65(4), 650–660. https://doi.org/10.24953/turkjped.2023.166

D’Antongiovanni, V., Pellegrini, C., Benvenuti, L., Fornai, M., Di Salvo, C., Natale, G., Ryskalin, L., Bertani, L., Lucarini, E., Di Cesare Mannelli, L., Ghelardini, C., Nemeth, Z. H., Haskó, G., & Antonioli, L. (2022). RETRACTED ARTICLE: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis. Inflammation, 45(4), 1829–1847. https://doi.org/10.1007/s10753-022-01663-8

Chen, K., Hu, Q., Xie, Z., & Yang, G. (2022). Monocyte NLRP3‐IL‐1β Hyperactivation Mediates Neuronal and Synaptic Dysfunction in Perioperative Neurocognitive Disorder. Advanced Science, 9(16). Portico. https://doi.org/10.1002/advs.202104106